Cardiovascular Health

Palliative care is crucial for safe and effective medication management to relieve symptoms and improve quality of life.

Joseph Saseen offers valuable insights into the implications of the added performance and quality measures for patients and health care providers.

Craig Beavers discusses significance of the 2024 update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure.

In recent years, telestroke services have transformed stroke care delivery, especially in rural or underserved areas.

Risk of developing anxiety or depression is highest within the first year after cardiovascular hospitalization.

Non-steroidal mineralocorticoid receptor antagonist, finerenone, demonstrated improved efficacy compared with existing steroidal treatment for patients.

Tirzepatide demonstrates statistically significant improvements in adult patients who have heart failure with preserved ejection fraction and obesity.

Cholesterol-lowering agents, like statins, reduced the risk of major adverse cardiovascular events and cardiovascular disease in patients with HIV.

The designation is based on animal model studies that have demonstrated superior efficacy in comparison to sildenafil.

Pharmacists can help patients with polycystic ovary syndrome safely incorporate complementary supplements, such as cinnamon, into their treatment plan.

One of the most important drivers of a patients’ uncontrolled hypertension is medication nonadherence.

New strategies can improve cholesterol management in patients with ASCVD.

Patient monitoring significantly improved for patients seen in the pharmacist-led clinic due to greater efforts to order labs per policy and prescribe an appropriate DOAC dose.

The findings showed that pharmacist-led interventions resulted in the greatest systolic blood pressure reductions.

Anatomical alterations result in many downstream changes, such as changes in pH, gastric volume, food intake, surface area for absorption, gastric emptying and transit times, and intestinal enzymes and efflux pumps, among others.

The findings highlight the possibility of pharmacists expanding their responsibilities in the provision of other clinical services in community pharmacy practice.

Increased awareness of women's cardiovascular health and the impact of estrogen fluctuation throughout women’s lives on cardiovascular disease could both boost the economy and improve health outcomes.

Because decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.

Previous studies have shown that individuals living with HIV are at higher risk for heart disease than individuals without HIV

Older adults who take aspirin for primary prevention of cardiovascular disease are at an increased risk of bleeding.

Pulsed field ablation may offer patients an efficacious treatment option with limited damage to surrounding tissues.

Palliative care may help reduce symptoms and improve quality-of-life for patients with cardiovascular disease.

Perinatal depression increases the risk of cardiovascular disease in women.

Semaglutide significantly improved heart failure symptoms and quality of life through weight loss and direct effects on heart tissue.